Addex Therapeutics share price logo

Addex Therapeutics

NASDAQ: ADXN

$3.75

+0.23

(+6.53%)

Live

as on

Addex Therapeutics Stock Performance

as on September 4, 2026 at 1:20 am IST

  • $3.75
    $3.75
  • 52 Week's Low

    52 Week's High

    $3.63
    $12.05
    downward going graph

    3.21%

    Downside

    221.33%

    Upside

    downward going graph

Addex Therapeutics share price movements today

Previous Close
$3.52
Open
$3.75
Volume
1.3K
Market Cap
$4.6M
Day's Low - High
$3.75 - $3.75
52 Week Low - High
$3.63 - $12.05

Addex Therapeutics Historical Returns

1 Month Return
-29.81 %
3 Month Return
-42.97 %
1 Year Return
-54.88 %
3 Year Return
-59.8 %
5 Year Return
-98.13 %

Addex Therapeutics Stock Fundamentals & Key Indicators

Check Addex Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.6M

EPS (TTM)

-6.97

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.47

Industry PE ratio

-2.904188679245283

PEG Ratio

0.0026565458488432567

EBITDA

-7.1M

Revenue (TTM)

74.0K

Profit Margin

84.32%

Return On Equity TTM

-131.35%

Addex Therapeutics Stock Valuation

Track how Addex Therapeutics P/E has moved over time to understand its valuation trends.

Addex Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-2.12x)

December 31, 2021

Industry (-2.90x)

March 31, 2026

Today (-0.89x)

March 31, 2026

Highest (0.76x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.89x

Addex Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Addex Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$4.6M-98.13%-0.4784.32%NA
BUY$44.6B614.61%NA0.00%NA
BUY$137.9B174.9%31.9286.04%NA
BUY$61.6B-61.21%-7.98-12.57%NA
BUY$82.3B21.91%19.984.86%0.44%

Stock Returns calculator for Addex Therapeutics Stock including INR - Dollar returns

The Addex Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Addex Therapeutics investment value today

Current value as on today

₹49,723

Returns

-₹50,277

(-50.28%)

Returns from Addex Therapeutics Stock

-₹53,646 (-53.65%)

Dollar Impact

₹3,369 (+3.37%)

Analyst Recommendation on Addex Therapeutics Stock

Based on 10 analysts

SELL

10.00%

Buy

20.00%

Hold

70.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'SELL' rating for Addex Therapeutics. Average target price of $30

Addex Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Addex Therapeutics.

What analysts predicted

87.5%UPSIDE

Target Price

$30

Current Price

$3.75

Analyzed by

10 Analysts

Target

$30.00

Addex Therapeutics target price $30, a slight upside of 87.5% compared to current price of $3.75. According to 10 analysts rating.

Indian Investors' Interest in Addex Therapeutics Stock

Search interest for Addex Therapeutics Stock has increased by 380% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:380% versus previous 30 day period

Addex Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
-
0
0
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-4
-3
0
0
0
0
0
0
0
0
EBITDA
-4
-3
0
0
0
0
-1
-1
-1
-1
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-3
0
0
0
0
-1
-1
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-3
-2
-2
-2
-3
-1
-1
-1
-1
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
100.00%
-369.76%

Addex Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Total Revenue
0
6
2
3
2
1
1
0
0
Gross Profit
0
5
2
3
2
1
1
0
0
Operating Income
-3
-1
-14
-12
-15
-10
-2
-2
-2
EBITDA
-3
-1
-14
-12
-14
-10
-2
-4
-6
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-1
-14
-12
-15
-10
-2
-4
-6
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-3
-1
-14
-12
-15
-20
-10
7
-6
Net Profit Margin
94.05%
97.61%
91.67%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Addex Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Mar 2024
Sep 2024
Mar 2025
Sep 2025
Mar 2026
Net Income
-4
-3
-2
-2
-2
-3
-1
-1
-1
-1
Operating Cash Flow
-2
-3
-2
-2
-2
-2
0
0
0
0
Investing Cash Flow
0
0
0
0
0
-
0
-
0
-
Financing Cash Flow
4
0
1
4
0
0
0
0
0
0
Change in Cash
1
-3
-1
1
-2
-2
0
0
0
0

Addex Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Mar 2020
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Mar 2025
Mar 2026
Net Income
-3
-1
-14
-12
-15
-20
-10
7
-6
Operating Cash Flow
-2
1
-9
-12
-14
-16
-7
-5
-2
Investing Cash Flow
0
0
0
0
0
0
0
4
0
Financing Cash Flow
3
37
0
0
16
3
5
0
1
Change in Cash
1
39
-10
-12
1
-13
-3
0
-1

Global Institutional Holdings in Addex Therapeutics

Funds
Holdings
Morgan Stanley - Brokerage Accounts
0.03%
Rhumbline Advisers
0.01%
GAMMA Investing LLC
0.01%
SBI Securities Co Ltd
0%
JPMorgan Chase & Co
0%

Insights on Addex Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -2.29M → -1.71M (in $), with an average increase of 34.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 583.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 95.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 36.37K → 7.69K (in $), with an average decrease of 37.6% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, ADXN stock has moved down by -32.3%

About Addex Therapeutics

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication; and GABAB PAM for the treatment pain, anxiety, addiction, chronic cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.
OrganisationAddex Therapeutics
HeadquartersChemin des Mines, 9, Geneva, Switzerland, 1202
IndustryBiotechnology
CEOMr. Timothy Mark Dyer
E-voting on sharesClick here to vote

Key Management of Addex Therapeutics

Name

Title

Dr. Roger G. Mills M.D.

Chief Medical Officer & Director

Mr. Lénaic Teyssédou

Head of Finance

Dr. Mikhail Kalinichev Ph.D.

Head of Translational Science

Mr. Timothy Mark Dyer

Co-Founder, CEO & Director

FAQs

What is Addex Therapeutics share price today?

Addex Therapeutics share price today is $3.75 as on . Addex Therapeutics share today touched a day high of $3.75 and a low of $3.75.

What is the 52 week high and 52 week low for Addex Therapeutics share?

Addex Therapeutics share touched a 52 week high of $12.05 on and a 52 week low of $3.63 on . Addex Therapeutics stock price today i.e. is trending at $3.75,which is 68.88% down from its 52 week high and 3.32% up from its 52 week low.

What is Addex Therapeutics's market capitalisation today?

Addex Therapeutics market capitalisation is $0.00T as on .

How to invest in Addex Therapeutics Stock (ADXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Addex Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Addex Therapeutics Shares that will get you 0.4000 shares as per Addex Therapeutics share price of $3.75 per share as on September 3, 2026 at 7:50 pm IST.

What is the minimum amount required to buy Addex Therapeutics Stock (ADXN) from India?

Indian investors can start investing in Addex Therapeutics (ADXN) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Addex Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Addex Therapeutics share’s latest price of $3.75 as on September 3, 2026 at 7:50 pm IST, you will get 2.6667 shares of Addex Therapeutics. Learn more about fractional shares .

What are the returns that Addex Therapeutics has given to Indian investors in the last 5 years?

Addex Therapeutics stock has given -98.13% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?